Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial

Eric G. Meissner, Mary McLaughlin, Lindsay Matthews, Ahmed M. Gharib, Bradford J. Wood, Elliot Levy, Ralph Sinkus, Kimmo Virtaneva, Dan Sturdevant, Craig Martens, Stephen F. Porcella, Zachary D. Goodman, Bittoo Kanwar, Robert P. Myers, Mani Subramanian, Colleen Hadigan, Henry Masur, David E. Kleiner, Theo Heller, Shyam KottililJoseph A. Kovacs, Caryn G. Morse*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

77 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science